Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Aug;108(2):265-8.
doi: 10.1067/mai.2001.116573.

Decline of CD3-positive T-cell counts by 6 months of age is associated with rapid disease progression in HIV-1--infected infants

Affiliations

Decline of CD3-positive T-cell counts by 6 months of age is associated with rapid disease progression in HIV-1--infected infants

J Chinen et al. J Allergy Clin Immunol. 2001 Aug.

Abstract

Because HIV-1 infected infants with rapid progression (RP) of disease might benefit from early and intense antiretroviral therapy, the identification of predictive factors of RP becomes extremely important. Currently, the best predictive factors of RP in HIV-1 infected children are HIV-1 RNA levels and CD4-positive T-cell counts. A decrease in CD3-positive T-cell count has been identified as a predictive factor of AIDS development in HIV-1 infected adults. Our objective was to evaluate decreased number of CD3-positive T-cells as a predictive factor of RP in infants. Peripheral blood lymphocytes from HIV-1 infected infants (up to 6 months of age) were analyzed for an association of lymphocyte subsets with RP, which was defined as the occurrence of AIDS or death before 18 months of age. In infants with RP (n = 32), CD3-positive T-cell counts were 3093 cells/microL at <1 month of age, 3092 cells/microL at 1 to 3 months, and 2062 cells/microL at 3 to 6 months. Non-RP infants (n = 49) maintained their CD3-positive T-cells counts at approximately 4000 cells/microL for at least 6 months of life. CD3-positive and CD4-positive T-cell counts were significantly associated with RP. Our results suggest that a decreased CD3-positive T-cell count may be used to predict RP in HIV-1 infected infants (RR = 2.16, P =.001).

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
T-cell subset counts from HIV-infected infants with RP of disease (○) and HIV-infected infants with non-RP of disease (●) during their first 6 months of age. A, CD3-positive T cells. B, CD4-positive T cells. C, CD8-positive T cells. The numbers of subjects at each time interval are given under the graphs.

References

    1. Centers for Disease Control. US HIV-1-AIDS cases reported through June 1999. Atlanta: CDC; HIV-1/AIDS surveillance report 1999; pp. 1–28.
    1. Centers for Disease Control and Prevention. 1994 revised classification for human immunodeficiency virus infection in children less than 13 years of age. Mor Mortal Wkly Rep CDC Surveill Summ. 1994;43:1–10.
    1. Mayaux M-J, Burgard M, Teglas J-P, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. JAMA. 1996;275:606–10. - PubMed
    1. MMWR. Guidelines for use of antiretroviral agents in pediatrics HIV-1 infection. Mor Mortal Wkly Rep. 1998;47:1–43.
    1. Mofenson LM, Korelitz J, Meyer WA, et al. The relationship between serum human immunodeficiency virus type 1 (HIV-1-1) RNA level, CD4-positive lymphocyte percent, and long term mortality risk in HIV-1-1 infected children. J Infect Dis. 1997;175:1029–38. - PubMed

Publication types